Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival
- 15 February 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 105 (4) , 1759-1767
- https://doi.org/10.1182/blood-2004-05-2006
Abstract
Constitutively activating internal tandem duplication (ITD) mutations of the receptor tyrosine kinase FLT3 (Fms-like tyrosine kinase 3) play an important role in leukemogenesis, and their presence is associated with poor prognosis in acute myeloid leukemia (AML). To better understand FLT3 signaling in leukemogenesis, we have examined the changes in gene expression induced by FLT3/ITD or constitutively activated wild-type FLT3 expression. Microarrays were used with RNA harvested before and after inhibition of FLT3 signaling. Pim-1 was found to be one of the most significantly down-regulated genes upon FLT3 inhibition. Pim-1 is a proto-oncogene and is known to be up-regulated by signal transducer and activator of transcription 5 (STAT5), which itself is a downstream target of FLT3 signaling. Quantitative polymerase chain reaction (QPCR) confirmed the microarray results and demonstrated approximately 10-fold decreases in Pim-1 expression in response to FLT3 inhibition. Pim-1 protein also decreased rapidly in parallel with decreasing autophosphorylation activity of FLT3. Enforced expression of either the 44-kDa or 33-kDa Pim-1 isotypes resulted in increased resistance to FLT3 inhibition-mediated cytotoxicity and apoptosis. In contrast, expression of a dominant-negative Pim-1 construct accelerated cytotoxicity in response to FLT3 inhibition and inhibited colony growth of FLT3/ITD-transformed BaF3 cells. These findings demonstrate that constitutively activated FLT3 signaling up-regulates Pim-1 expression in leukemia cells. This up-regulation contributes to the proliferative and antiapoptotic pathways induced by FLT3 signaling. (Blood. 2005;105: 1759-1767)Keywords
This publication has 46 references indexed in Scilit:
- FLT3 ligand causes autocrine signaling in acute myeloid leukemia cellsBlood, 2004
- A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivoBlood, 2002
- Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathwaysBlood, 2000
- Constitutive activation of FLT3 stimulates multiple intracellular signal transducers and results in transformationLeukemia, 2000
- Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell linesOncogene, 2000
- Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cellsBritish Journal of Haematology, 2000
- Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the productLeukemia, 1998
- Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell linesLeukemia, 1997
- Expression of the hematopoietic growth factor receptor FLT3 (STK- 1/Flk2) in human leukemiasBlood, 1996
- Expression of the FMS/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineagesBlood, 1992